Natus Medical (NASDAQ:BABY) will report earnings before markets open on Wednesday, May 29th. Natus Medical Incorporated is a medical device company that develops, manufactures, and markets screening products. The Company’s products identify and monitor common medical disorders that may occur between conception to a baby’s first birthday. Natus is selling its ALGO products for newborn hearing screening, as well as its CO-Stat products for the evaluation of jaundice.
Here is your Cheat Sheet to Natus Medical Earnings:
Earnings Expectations: Analysts expect earnings of $0.11 per share on revenues of $84.47 million. Currently, the company’s P/E ratio stands at 108.08.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.18 to a profit $0.19. For the current year, the average estimate is a profit of $0.84, which is better than the estimate ninety days ago.
Here’s how Natus Medical has been performing on an annual basis:
|Revenue ($) in millions||162||167||219||233||292|
|Diluted EPS ($)||0.66||0.39||0.41||-0.41||0.12|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||59.51||61.01||80.72||90.45|
|Diluted EPS ($)||0.01||0.01||-0.07||0.16|
Natus Medical has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)